Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

The Food and Drug Administration (FDA) has approved Welireg ™ (belzutifan) for the treatment of adult and pediatric patients aged 12 years and older with locally advanced, unresectable, or metastatic ...

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was highly similar to Stelara.

Squeezed by insurers and middlemen, independent pharmacists such as Mr Jolley find themselves on the front lines of a tariff storm. Nearly everyone down the line — drugmakers, pharmacies, wholesalers, ...

In a cohort study, researchers evaluated the risk for ischemic and hemorrhagic stroke among individuals with type 1 and type ...

HealthDay News — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

HealthDay News — Adult-onset type 1 diabetes (T1D) is associated with an increased risk for death and major adverse cardiovascular events (MACE), according to a study published in the European Heart ...

Researchers conducted a cross-sectional survey study examining stimulant prescription trends by prescriber specialty and by ...

HealthDay News — Exposure to air pollution may worsen bone loss in postmenopausal women, according to a study published in the Journal of Bone and Mineral Research.

With an increasing geographic footprint, it is important for clinicians to be able to recognize and treat coccidioidomycosis, or valley fever, in susceptible patient populations.

WHI research has been pivotal in women's health, but recent plans for funding termination raise questions about its future.